In an effort to create a framework for evaluating the relationship between tumor and wounds, Howard Chang and his colleagues in Patrick Brown's lab at Stanford University examined the gene expression profile of fibroblasts responding to serum in cell culture--a process that shares certain features with wound healing. Fibroblasts are involved in wound healing, and serum is encountered in the body where blood leaks out of blood vessels (such as sites of injury), and is thought to be a major initiator of the wound-healing response.
Though fibroblasts from different sites in the body differ in their properties and gene expression profiles, Brown and colleagues found that they share a common expression pattern in response to serum. From this expression profile, Chang et al. identified a core group of genes--a genetic signature--associated with a serum response. Because many of the genes in the signature were known to be involved in various wound-healing processes--such as matrix remodeling, cell motility, and angiogenesis--Chang et al. used this signature as a surrogate marker to measure how much tumors may be like wounds. When they compared the wound-like genetic signature with the expression profiles of various clinical tumor samples, they found the signature was always present in certain cancers--prostate and liver cell carcinomas--and occurred variably in others--breast, lung, and gas
Contact: Barbara Cohen
Public Library of Science